Interleukin-6, interleukin-1 gene cluster and interleukin-1 receptor polymorphisms in iranian patients with juvenile systemic lupus erythematosus

European Cytokine Network

Volumn 25, Issue 2, 2014, Pages 35-40

  Ziaee, Vahid ^a   Tahghighi, Fatemeh ^a   Moradinejad, Mohammad Hassan ^a   Harsini, Sara ^a   Mahmoudi, Maryam ^b   Rezaei, Arezou ^a   Soltani, Samaneh ^c   Sadr, Maryam ^c   Aghighi, Yahya ^d   Rezaei, Nima ^a,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Children; Interleukin 1; Interleukin 6; Single nucleotide polymorphism; Systemic lupus erythematosus

Indexed keywords

GENOMIC DNA; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; IL6 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR; ISOPROTEIN;

ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA FRAGMENTATION; GENE CLUSTER; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; CHILD; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; IRAN; MALE; MULTIGENE FAMILY; PATHOLOGY; PRESCHOOL CHILD; PROMOTER REGION;

ADOLESCENT; ALLELES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; IRAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MULTIGENE FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; RECEPTORS, INTERLEUKIN-1;

EID: 84925884100     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2014.0352     Document Type: Article

References (46)

1. Yap DYH, Lai KN. The role of cytokines in the pathogenesis of systemic lupus erythematosus-from bench to bedside. Nephrology 2013; 18: 243.
2. Tsao BP. Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 2004; 16: 513.
3. Hirano T. Interleukin 6 and its receptor: ten years later. Int Rev Immunol 1998; 16: 249.
4. Muraguchi A, Hirano T, Tang B, et al. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 1988; 167: 332.
5. Lotz M, Jirik F, Kabouridis P, et al. B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J Exp Med 1988; 167: 1253.
6. Sachs L, Lotem J, Shabo Y. The molecular regulators of macrophage and granulocyte development. Ann N Y Acad Sci 1989; 557: 417.
7. Gröndal G, Gunnarsson I, Rönnelid J, Rogberg S, Klareskog L, Lundberg I. Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 1999; 18: 565.
8. Linker-Israeli M, Deans R, Wallace D, Prehn J, Ozeri-Chen T, Klinenberg J. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 1991; 147: 117.
9. Alheim K, Bartfai T, Interleukin-1 System: Receptors T. Ligands, and ICE in the Brain and Their Involvement in the Fever Response. Ann N Y Acad Sci 1998; 840: 51.
10. Bresnihan B, Cunnane G. Interleukin-1 receptor antagonist. Rheum Dis Clin North Am 1998; 24: 615.
11. Arend WP. Interleukin-1 receptor antagonist. Adv Immunol 1993; 54: 167.
12. Brugos B, Kiss E, Dul C, et al. Measurement of interleukin-1 receptor antagonist in patients with systemic l upus erythematosus could pre-dict renal manifestation of the disease. Hum Immunol 2010; 71: 874.
13. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095.
14. Sturfelt G, Roux-Lombard P, Wollheim F, Dayer J. Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosus. Rheumatology 1997; 36: 1283.
15. Aringer M, Smolen J. Cytokine expression in lupus kidneys. Lupus 2005; 14: 13.
16. Barkhordari E, Rezaei N, Ansaripour B, et al. Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome. J Clin Immunol 2010; 30: 74.
17. Amirzargar A, Shahram F, Nikoopour E, et al. Proinflammatory cytokine gene polymorphisms in Behcet's disease. Eur Cytokine Netw 2010; 21: 292.
18. Mahdaviani SA, Rezaei N, Moradi B, Dorkhosh S, Amirzargar AA, Movahedi M. Proinflammatory cytokine gene polymorphisms a mongIranian patients with asthma. J Clin Immunol 2009; 29: 57.
19. Rezaei N, Amirzargar AA, Shakiba Y, Mahmoudi M, Moradi B, Aghamohammadi A. Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency. Clin Exp Immunol 2009; 155: 21.
20. Amirzargar AA, Bagheri M, Ghavamzadeh A, et al. Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia. Int J Immunogenet 2005; 32: 167.
21. Amirzargar AA, Rezaei N, Jabbari H, et al. Cytokine single nucleotide polymorphisms in Iranian patients with pulmonary tuberculosis. Eur Cytokine Netw 2006; 17: 84.
22. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
23. Amirzargar AA, Naroueynejad M, Khosravi F, et al. Cytokine single nucleotide polymorphisms in Iranian populations. Eur Cytokine Netw 2008; 19: 104.
24. Miller S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
25. Amirzargar A, Bagheri M, Ghavamzadeh A, et al. Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia. Int J Immunogenet 2005; 32: 167.
26. Amirzargar A, Shahram F, Nikoopour E, et al. Proinflammatory cytokine gene polymorphisms in Behcet's disease. Eur Cytokine Netw 2010; 21: 292.
27. Amirzargar AA, Rezaei N, Jabbari H, et al. Cytokine single nucleotide polymorphisms in Iranian patients with pulmonary tuberculosis. Eur Cytokine Netw 2006; 17: 84.
28. Camargo J, Correa P, Castiblanco J, Anaya J. Interleukin-1÷ polymorphisms in Colombian patients with autoimmune rheumatic diseases. Genes Immun 2004; 5: 609.
29. Dinarello C. The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 2002; 20: S1.
30. Jandl RC, George JL, Dinarello CA, Schur PH. The effect of interleukin 1 on IgG synthesis in systemic lupus erythematosus. Clin Immunol Immunopathol 1987; 45: 384.
31. Iacoviello L, Di Castelnuovo A, Gattone M, et al. Polymorphisms of the interleukin-1÷ gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol 2005; 25: 222.
32. Tahmasebi Z, Akbarian M, Mirkazemi S, et al. Interleukin-1 gene cluster and IL-1 receptor polymorphisms in Iranian patients with systemic lupus erythematosus. Rheumatol Int 2013; 33: 2591.
33. Parks C, Cooper G, Dooley M, et al. Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States. Ann Rheum Dis 2004; 63: 91.
34. Tsai LJ, Hsiao SH, Tsai JJ, Lin CY, Tsai LM, Lan JL. Higher genetic susceptibility to inflammation in mild disease activity of systemic lupus erythematosus. Rheumatol Int 2009; 29: 1001.
35. Huang CM, Wu MC, Wu JY, Tsai FJ. Lack of association of interleukin-1ß gene polymorphisms in Chinese patients with systemic lupus erythematosus. Rheumatol Int 2002; 21: 173.
36. Wang B, Zhu JM, Fan YG, et al. The association of IL1 and IL1÷ polymorphisms with susceptibility to systemic lupus erythematosus:A meta-analysis. Gene 2013; 527: 95.
37. Tsai LJ, Lan JL, Lin CY, Hsiao SH, Tsai LM, Tsai JJ. The different expression patterns of interleukin-1 receptor antagonist in systemic lupus erythematosus. Tissue Antigens 2006; 68: 493.
38. Godarzi EM, Sarvestani EK, Aflaki E, Amirghofran Z. Interleukin-6 gene polymorphism in Iranian patients with systemic lupus erythematosus. Clin Rheumatol 2011; 30: 179.
39. Schotte H, Schlüter B, Rust S, Assmann G, Domschke W, Gaubitz M. Interleukin-6 promoter polymorphism (- 174 G/C) in Caucasian German patients with systemic lupus erythematosus. Rheumatology 2001; 40: 393.
40. Huang CM, Huo AP, Tsai CH, Chen CL, Tsai FJ. Lack of association of interleukin-6 and interleukin-8 gene polymorphisms in Chinese patients with systemic lupus erythematosus. J Clin Lab Anal 2006; 20: 255.
41. Guarnizo-Zuccardi P, Lopez Y, Giraldo M, et al. Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus. Tissue Antigens 2007; 70: 376.
42. Santos MJ, Fernandes D, Capela S, da Silva JC, Fonseca JE. Interleukin-6 promoter polymorphism -174 G/C is associated with nephritis in Portuguese Caucasian systemic lupus erythematosus patients. Clin Rheumatol 2011; 30: 409.
43. Hrycek A, Siekiera U, Cieslik P, Szkrobka W. HLA-DRB1-DQB1 alleles and gene polymorphisms of selected cytokines in system iclupus erythematosus. Rheumatol Int 2005; 26: 1.
44. Asano NM, Angelo HD, da Silva HA, Maia MM, Lins OG, Souza PE. Interleukin-6 promoter polymorphisms -174 GC in B razil-ian patients with systemic lupus erythematosus. Hum Immunol 2013; 74: 1153.
45. Chua K, Kee B, Tan S, Lian L. Interleukin-6 promoter polymorphisms (-174 G/C) in Malaysian patients with systemic lupus erythematosus. Braz J Med Biol Res 2009; 42: 551.
46. Hristova M, Dourmishev L, Kamenarska Z, et al. Role of the Promoter Polymorphism IL-6-174 G/C in Dermatomyositis and Systemic Lupus Erythematosus. Biomed Res Int 2013; 2013.